Brief: Hansa Biopharma Proposes Peter Nicklin As New Chair
30/05/2022 15:45
May 30 (Reuters) - Hansa Biopharma AB HNSA.ST :
* NOMINATION COMMITTEE IN HANSA BIOPHARMA PROPOSES PETER
NICKLIN
AS NEW CHAIR OF THE BOARD OF DIRECTORS AT THE ANNUAL GENERAL
MEETING 2022
* CURRENT CHAIR ULF WIINBERG HAS CHOSEN TO NOT STAND FOR
RE-ELECTION
Source text for Eikon: ID:nWkr5k388M
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS